Gastric or Gastroesophageal Junction Adenocarcinoma (GEC)
2 clinical trials · Condition
◉ Watch Gastric or Gastroesophageal Junction Adenocarcinoma (GEC)
| Record | Firm | Date |
|---|---|---|
| Tucatinib Continuation Study (NCT07768358) | Pfizer | 2026-08-24 |
| Safety and Pharmacokinetics of Tucatinib (MK-7119) in Chinese Participants With Cancer (MK-7119-002) (NCT05382364) | Pfizer | 2022-06-29 |
Track Gastric or Gastroesophageal Junction Adenocarcinoma (GEC) automatically
Every clearance here is in the API, with alerts when new ones post.